Canada NewsWire TORONTO, March 3, 2025 TORONTO, March 3, 2025 /CNW/ - Biogen Canada Inc. announced today that Health Canada has issued marketing authorization with conditions (Notice of Compliance with Conditions (NOC/c)) for QALSODY™ ...
PR Newswire THOUSAND OAKS, Calif., March 1, 2025 Significantly Reduced Nasal Congestion, Polyp Size and Nearly Eliminated Need for Surgery Data Published in NEJM and Presented at AAAAI/WAO 2025 THOUSAND OAKS, Calif., March 1, 2025 ...
PR Newswire BOSTON, Feb. 28, 2025 Preclinical data with BBT001 demonstrate its best-in-disease potential for improved efficacy and dosing convenience compared to approved biologics in atopic dermatitis Interim safety and pharmacokinetic ...
PR Newswire STOCKHOLM, Feb. 28, 2025 STOCKHOLM, Feb. 28, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced today that the Committee for Medicinal Products for Human Use (CHMP) of the ...
PR Newswire BEDMINSTER, N.J., Feb. 28, 2025 - ODACTRA is now indicated to treat house dust mite (HDM)-induced allergic rhinitis, with or without conjunctivitis, in children ages 5 through 11 years, in addition to patients 12 through 65 years ...
Canada NewsWire OAKVILLE, ON, Feb. 28, 2025 Positive CDA and INESSS reimbursement recommendations are an important step towards public access to BIMZELX®, the first and only treatment approved by Health Canada for eligible patients with ...
PR Newswire NORTH CHICAGO, Ill., Feb. 28, 2025 NORTH CHICAGO, Ill., Feb. 28, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a ...
PR Newswire SAN DIEGO, Feb. 27, 2025 SAN DIEGO, Feb. 27, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced top-line data from a Phase 4 study, KINECT-PRO™, demonstrating clinically meaningful and sustained ...
Canada NewsWire WINNIPEG, MB, Feb. 27, 2025 Additional agreement will improve access and affordability of drugs for rare diseases WINNIPEG, MB, Feb. 27, 2025 /CNW/ - No one should have to choose between paying for prescription drugs and ...
PR Newswire MINNEAPOLIS, Feb. 26, 2025 MINNEAPOLIS, Feb. 26, 2025 /PRNewswire/ -- For children and teens living with migraine, there may be a new preventive treatment, according to a preliminary study released February 26, 2025, that will be ...
Lecanemab use is higher among white, male, urban, and wealthier patients despite broad Medicare coverage.
New antifungal nanotechnology uses targeted liposomes to boost drug delivery and fight Candida infections.
Real-world evidence shows long-term use of oral and inhaled steroids increases the risk of adrenal insufficiency, highlighting the need for proper treatment alternatives.
Legalizing and increased consumption of cannabis has led to increased cases of people visiting hospitals, many due to anxiety, psychosis, and other mental health disorders.
Glucagon-like peptide-1 receptor agonists improve cardiovascular outcomes and reduce mortality in patients with type 2 diabetes.
Subscribe to our Free Newsletters!
Medindia's policies are aligned with the United Nations Sustainable Development Goals (SDGs) - SDG 3, SDG 4, SDG 5, SDG 6 , SDG 10 & SDG 12.
Disclaimer - All information and content on this site are provided for informational and educational purposes only. They should NOT be used for the diagnosis or treatment of any health-related condition or disease. Always consult a qualified healthcare professional for medical advice, diagnosis, or treatment. Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2025
Careers